TH Capital invests in Saifu Pharmaceutical Research Institute Co., Ltd., the leading CRO and backbone of Chinas innovative drug industry Beijing, 23 September 2021 – Saifu Pharmaceutical Research Institute Co., Ltd. (SAFE Pharma) recently announced the completion of its RMB 300 million Series C funding round. TH Capital is excited to complete the second investment in the highly attractive CRO space al...

On December 6 – 8 the Chinese investment industry association Zero2IPO held the 17th annual China Equity Investment Forum in Beijing. TH Capital joined the event as the officially ranked fund manager and the firm´s Managing Director Wang Aihong participated in the panel on current investment strategies, sharing insights into TH Capital´s Top-Down investment approach. The event was crowned by the off...

During the annual Prism Awards ceremony, held on January 31 2018 at the SPIE Photonics West in San Francisco, California, German industry leader LIMO was awarded the highest honor of the global optoelectronic industry in the category of Material Processing & Additive Manufacturing. LIMO is a subsidiary of TH Capital invested FocusLight, making the Xi’an based industry leader the first Chinese comp...

Rafael Ratzel - Head of International Business at TH Capital - joined the "Investing in Europe Summit 2017" as a panel speaker alongside other senior executives from the Chinese PE industry. The annual event brings together Chinese financial and strategic investors seeking investment opportunities in Europe and highlights key developments and trends in the industry and market. During the pane...

During their annual “2017 Global Science and Technology Innovation Conference" held on 7th November in Xi. Among the thousands of fund managers registered in China, TH Capital ranked among the ten best technology investors in the country.We are particularly proud that our top-down analysis based strategy is recognized not only by our LPs based on superior returns distributed, but also by independ...